THE US Food and Drug
Administration has revealed a
US$25m plan to be run over the
next 12 months to update its
prescription drug, device and food
safety review tools, under its
Regulatory Science Initiative.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 07 Oct 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Oct 10
THE NSW Health Care Complaints Commission (HCCC) has prosecuted a complaint against pharmacist Nicholas Fearon before the NSW Civil and Administrative Tribunal, which found him guilty of unsatisfactory professional conduct and professional misconduct, and having been convicted of a criminal offence in NSW, was not a suitable person to hold registration as a pharmacist.
SIGMA Healthcare says 2017/18 was a “challenging year” during which it continued to execute its long term strategy despite declining sales due to softening consumer sentiment and reduced demand for low-margin Hepatitis C drugs.